Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

VIZ ACCESS HCM - Multi-Site Registry

NCT: NCT07103057 · TERMINATED

NCT IDNCT07103057
StatusTERMINATED
Start Date2025-06-13
Completion2026-09-17
SponsorViz.ai, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

To describe the clinical, economic, and population characteristics of newly diagnosed, previously diagnosed, and suspected patients evaluated by Viz HCM. HCM is underdiagnosed in the community and AI algorithms have been developed as screening tools. However, it is not well understood how to best integrate AI screening tools and their potential impact.

Frequently Asked Questions

What is VIZ ACCESS HCM - Multi-Site Registry?

VIZ ACCESS HCM - Multi-Site Registry is a clinical trial registered under NCT07103057. Current status: TERMINATED.

What is the status of NCT07103057?

The current status of NCT07103057 (VIZ ACCESS HCM - Multi-Site Registry) is: TERMINATED.

When did VIZ ACCESS HCM - Multi-Site Registry start?

VIZ ACCESS HCM - Multi-Site Registry started on 2025-06-13.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.